NO MORE EMBRYONIC ETHICAL ISSUES. “Clearly, using hiPSCs (iPS) in regenerative medicine removes the hESC-associated (embryonic stem cell) ethical issues that resulted in restricted funding of this research in the USA and other countries. It also raises the possibility of autologous transplantation.”
http://hmg.oxfordjournals.org/content/early/2013/08/19/hmg.ddt379.full
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022